What is the prevalence of Marinesco-Sjögren Syndrome?

Marinesco-Sjögren syndrome is an ultra-rare multisystem disorder with an estimated prevalence of less than 1 in 1,000,000 individuals worldwide. Due to the condition's complex clinical presentation, it is significantly underdiagnosed, meaning the true number of people living with Marinesco-Sjögren syndrome is likely higher than current literature suggests.

How common is Marinesco-Sjögren syndrome?

Marinesco-Sjögren syndrome is classified as an ultra-rare disease. Because fewer than 200 cases have been documented in medical literature, accurate incidence rates remain unknown. While Marinesco-Sjögren syndrome appears to affect males and females equally, the rarity of the condition makes it difficult to establish definitive epidemiological trends across different ethnic or geographic populations.

What is the typical age of onset for Marinesco-Sjögren syndrome?

The clinical manifestations of Marinesco-Sjögren syndrome typically emerge in early childhood. Patients generally present with a combination of cerebellar ataxia, cataracts, and muscle weakness. While these features are characteristic of Marinesco-Sjögren syndrome, the severity and progression can vary significantly between individuals, which contributes to challenges in early clinical recognition.

Why is accurate data on Marinesco-Sjögren syndrome limited?

Several factors complicate the gathering of precise statistics for Marinesco-Sjögren syndrome:

• Underdiagnosis: The overlap of symptoms with other more common ataxias can lead to misdiagnosis.


• Genetic Complexity: Mutations in the SIL1 gene are the primary cause, but genetic testing is not universally accessible.


• Data Fragmentation: Rare disease registries are often siloed, making global case counting difficult.


• Community Insights: Currently, 9 individuals with Marinesco-Sjögren syndrome have joined the DiseaseMaps.org community, providing invaluable, real-world data that complements formal clinical research.

Next steps

• Consult a clinical geneticist to discuss molecular testing for SIL1 gene mutations.


• Connect with the DiseaseMaps.org community to share experiences and learn from other families affected by this condition.


• Seek a multidisciplinary care team, including a neurologist and ophthalmologist, to manage the multisystem symptoms of the disease.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• Orphanet: Marinesco-Sjögren syndrome (ORPHA:558)


• NIH Genetic and Rare Diseases Information Center (GARD): Marinesco-Sjögren syndrome


• OMIM (Online Mendelian Inheritance in Man): Entry #248800


• PubMed: Clinical and genetic spectrum of Marinesco-Sjögren syndrome